CEOs On The COVID Legacy: Medtech Readies For ‘A World That Will Never Be The Same’
Tom Polen, Kevin Lobo And Nacho Abia Give Their Views On COVID’s Effect On Supply Chain, Medtech Innovation And Omnichannel
The medtech industry’s successful response to the COVID-19 challenge has in some ways made the pre-pandemic years feel like a lifetime ago, in terms of service delivery. That was the consensus at a high-level Medtech Conference panel chaired by LEK consultancy group.
You may also be interested in...
The pressures on global medtechs to focus more on sustainability are internal as well as external. Scope 3 adds yet another layer of compliance. Johnson & Johnson’s EMEA VP for Surgical Vision Erin McEachren explains to In Vivo how her organization meets these challenges while simultaneously addressing EU Medical Device Regulation requirements and ensuring patient safety standards.
As the health care sector moves from linear to circular, medtechs, providers and patients all have roles to play in ensuring that current strategies, practices and behaviors contribute to guarantee a sustainable future. Part one of a short series on this theme looks as best practice for providers.
Outside the EU and no longer enjoying an MRA with the bloc, Switzerland has had to develop its own medical device database, work on which will continue into next year.